Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020615
Filing Date
2023-05-10
Accepted
2023-05-10 16:38:41
Documents
60
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q icvx-20230331.htm   iXBRL 10-Q 2557942
2 EX-31.1 icvx-ex31_1.htm EX-31 20480
3 EX-31.2 icvx-ex31_2.htm EX-31 19062
4 EX-32.1 icvx-ex32_1.htm EX-32 11027
5 EX-32.2 icvx-ex32_2.htm EX-32 11284
  Complete submission text file 0000950170-23-020615.txt   8589843

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT icvx-20230331_cal.xml EX-101.CAL 37495
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT icvx-20230331_lab.xml EX-101.LAB 450648
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT icvx-20230331.xsd EX-101.SCH 52774
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT icvx-20230331_def.xml EX-101.DEF 215765
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT icvx-20230331_pre.xml EX-101.PRE 345511
54 EXTRACTED XBRL INSTANCE DOCUMENT icvx-20230331_htm.xml XML 1574636
Mailing Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101
Business Address 1930 BOREN AVE., SUITE 1000 SEATTLE WA 98101 (206) 737-0085
Icosavax, Inc. (Filer) CIK: 0001786255 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40655 | Film No.: 23907174
SIC: 2836 Biological Products, (No Diagnostic Substances)